Tvardi Therapeutics Inc. (TVRD) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Tvardi Therapeutics Inc.

    NASDAQ: TVRD · Real-Time Price · USD
    40.23
    2.86 (7.65%)
    At close: Oct 03, 2025, 3:59 PM

    Tvardi Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023
    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023
    Revenue
    		 n/a 2.57M 1.46M 2.56M 991K 2.13M 3M 4.87M
    Cost of Revenue
    		 47K n/a n/a 73K 77K 620K 690K 1.62M
    Gross Profit
    		 -47K 2.57M 1.41M 2.48M 914K 1.51M 2.31M 3.25M
    Operating Income
    		 -8.87M -2.39M -6M -6.3M -16.21M -29.67M -4.66M -28.9M
    Interest Income
    		 377K n/a 421K 766K 689K 952K 313K 866K
    Pretax Income
    		 4.17M -4.91M -8.08M -12.48M -20.02M -30.7M -4.35M -28.03M
    Net Income
    		 4.17M -4.91M -7.68M -12.48M -20.02M -30.7M -4.35M -28.03M
    Selling & General & Admin
    		 3.06M 4.64M 6.83M 6.4M 6.37M 6.79M 682K 6.72M
    Research & Development
    		 5.81M 319K 171K 1.36M 9.27M 21.96M 3.98M 25.42M
    Other Expenses
    		 -47K n/a 454K 1.02M 1.49M 2.43M n/a n/a
    Operating Expenses
    		 8.82M 4.96M 7.46M 8.78M 17.13M 31.18M 4.66M 32.15M
    Interest Expense
    		 n/a 2.87M 2.62M 1.96M 1.91M 1.98M n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Cost & Expenses
    		 8.87M 4.96M 7.46M 8.86M 17.2M 31.8M 4.66M 33.76M
    Income Tax Expense
    		 n/a n/a -398K n/a n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 8.25M 9.36M 1.52M 1.52M 1.52M 9.36M 9.36M 1.51M
    Shares Outstanding (Diluted)
    		 8.46M 9.36M 1.52M 1.52M 1.52M 9.36M 9.36M 1.51M
    EPS (Basic)
    		 0.51 -0.52 -5.04 -8.19 -13.17 -3.28 -0.46 -18.61
    EPS (Diluted)
    		 -1 -0.52 -5.04 -8.19 -13.17 -3.28 -0.46 -18.61
    EBITDA
    		 -8.82M -2.04M -5.46M -10.44M -18.03M -28.67M -3.32M -27.51M
    EBIT
    		 -8.87M -2.04M -5.46M -10.52M -18.11M -28.71M -3.35M -28.03M
    Depreciation & Amortization
    		 47K n/a n/a 73K 77K 42K 24K 521K

    Add to Watchlist